We recently showed that the L protein of Sendai virus is present as an oligomer in the active P -L polymerase complex [Smallwood et al., Virology 304 (2002) 235]. We now demonstrate using two different epitope tags that the L protein of a second respirovirus, human parainfluenza type 3 virus (PIV3), also forms an L -L complex. L oligomerization requires the coexpression of the differentially epitope tagged L proteins. By exploiting a series of C-terminal truncations the L -L binding site maps to the N-terminal half of L. There is some complex formation between the heterologous PIV3 and Sendai L and P proteins; however, the heterologous L protein does not function in transcription of either the PIV3 or Sendai template. The PIV3 C protein binds PIV3 L and inhibits RNA synthesis in vitro and in vivo. Significant homology exists between the C proteins of PIV3 and Sendai and complex formation occurs between the PIV3 and Sendai heterologous C and L proteins. In addition, the heterologous C proteins can inhibit transcription at f50% of the level of the homologous protein. These data suggest that while the C proteins may be functionally somewhat interchangeable, the L and P proteins are specific for each virus. D
Introduction
The RNA-dependent RNA polymerase of paramyxoviruses is a complex of the L and P proteins, where the L protein is thought to contain all the catalytic activities necessary for viral RNA synthesis (for a review, Lamb and Kolakofsky, 2001) . The P protein of many paramyxoviruses has been shown or predicted to be an oligomer (Lamb and Kolakofsky, 2001 ) and the most detailed structural studies showed that Sendai P is a tetramer forming a coiled coil in the functional polymerase (Tarbouriech et al., 2000a (Tarbouriech et al., ,2000b . In Sendai, the L binding site mapped to the C-terminal half on P at amino acids (aa) 412-479 (Curran et al., 1994; Smallwood et al., 1994) . The P subunit of the polymerase functions in the stabilization and proper folding of L, as coexpression of P and L is necessary for complex formation, and L is unstable in the absence of P (Horikami et al., 1992 (Horikami et al., , 1997 . The P genes of the respirovirus genus within the paramyxovirus family encode multiple proteins including the C and V proteins (Lamb and Kolakofsky, 2001 ). In the case of Sendai, viral RNA synthesis is downregulated by the C proteins, by C binding to the L polymerase subunit (Cadd et al., 1996; Curran et al., 1992; Grogan and Moyer, 2001; Horikami et al., 1997) .
Sequence alignment of the L proteins of negative-stranded RNA viruses revealed six distinct regions of conservation, designated as domains I-VI, which were proposed to correspond to functional domains of the protein (Poch et al., 1990; Sidhu et al., 1993) . We have shown with a number of site-directed Sendai L mutants that each conserved domain contributes to multiple steps in viral RNA synthesis (Chandrika et al., 1995; Cortese et al., 2000; Feller et al., 2000a; Horikami and Moyer, 1995; Smallwood et al., 1999 Smallwood et al., , 2002a Smallwood et al., ,2002b . While the functional role of each domain is complex, the domains act in an independent fashion, because when pairs of inactive L mutants or a truncation of wild-type (wt) L with a mutant L were coexpressed, viral RNA synthesis is restored through intragenic complementation (Smallwood et al., 2002a (Smallwood et al., ,2002b . Consistent with intragenic complementation the functional form of the L protein was shown directly to be an oligomer by the coimmunoprecipitation of L proteins carrying two different epitope tags. Deletion analysis has shown that the L -L interaction site maps within the N-terminal 200 aa of L (C ßevik et al., 2003) . We identified amino acids in the N- terminal 360 aa of the L protein of Sendai virus which are essential for the binding of P, but are non-essential for L binding (C ßevik et al., 2003; Holmes and Moyer, 2002) , so the P and L binding sites on L are independent of one another. To determine if the oligomerization of L protein might be a general property of paramyxoviruses, we analyzed L of the related respirovirus, human parainfluenza virus 3 (PIV3). We show here that the L protein of PIV3 is also an oligomer where the L -L interaction site resides in the N-terminal half of L. Homologous and heterologous PIV3 and Sendai L, P and C interactions were tested for their function in RNA synthesis by both viruses.
Results

PIV3 L protein forms an oligomer
To test if the L protein of another member of the paramyxovirus family interacts with itself, PIV3 full-length (FL) L protein was differentially epitope tagged. HA or FLAG tags were cloned in frame at the 5V end of the L coding sequence as described under Materials and methods. Both tagged full-length (FL) L proteins were expressed at wt L levels and were shown to be 90 -100% as active as wt L in viral RNA synthesis in a CAT reporter minigenome assay (data not shown). A series of C-terminal truncations of the FLAG FL L (2258 aa), designated FLAG Bam L, FLAG Age L and FLAG Sph L with sizes of 1721, 1305 and 915 aa, respectively, were constructed by deletion of the FLAG FL L plasmid as described under Materials and methods. To test for L -L complex formation, the tagged proteins were expressed in VVT7-infected cells by transfection of the P plasmid and HA FL L and truncated FLAG L plasmids separately or together and labeled with Express-35 S. Analysis of total protein showed that all the proteins were synthesized (Fig. 1A) . Immunoprecipitation (IP) of the extracts with a-FLAG (Fig. 1B, Lane 2) or a-HA (Fig.  1C , Lanes 3, 5, 7 and 9) antibodies showed only a trace cross-reactivity for each antibody with the L protein with the heterologous tag expressed alone. IP with a-FLAG for each of the FLAG tagged truncations coimmunoprecipitated the HA FL L (Fig. 1B, Lanes 6, 8 and 10) . Similarly IP with a-HA coprecipitated each of the FLAG truncations with the HA FL L (Fig. 1C, Lanes 6, 8 and 10 ). The L -L complex was also formed in a similar experiment in the absence of P protein (Fig. 1D , Lane 5, bottom), so P is not required for the interaction. The coimmunoprecipitation of a complex with both antibodies suggests that the PIV3 L protein is an oligomer in the polymerase complex and the binding site resides in the N-terminal 915 aa of the protein.
The N-terminal 876 aa of the L proteins of both PIV3 and Sendai encompasses the conserved domains I-III. We tested if heterologous L -L interactions could occur with the L proteins of PIV3 and Sendai (SV) with the expectation that with a positive result, the data might contribute to identifying amino acids, perhaps in the conserved domains, required for oligomerization. The HA-tagged FL L protein of each virus was expressed with either a PIV3 or SV truncated FLAG L in the absence of any P protein and analysis of the total extract showed that all the proteins were expressed (Figs. 1D and E, top) . In the homologous interaction, immunoprecipitation with a-FLAG antibody of PIV3 FLAG Bam L also brought down PIV3 HA FL L compared with background binding with PIV3 HA FL L alone as above (Fig. 1D , Lanes 3 and 5). In addition, a-FLAG antibody coimmunoprecipitated SV FLAG Bak L and PIV3 HA FL L (Lane 6, bottom). In the converse experiment, immunoprecipitation with a-HA antibody of SV HA FL L brought down the heterologous PIV3 FLAG Bam L as well as the homologous SV FLAG Bak L (Fig. 1E , Lanes 5 and 6). When quantitated, these data show that heterologous L -L complexes can occur between the L proteins of Sendai and PIV3 at greater than 50% of the level of the homologous interactions.
To test the requirements for PIV3 L -L complex formation, we asked if the proteins must be coexpressed. Differ- entially tagged HA FL L and FLAG Bam L were expressed alone or together in the presence of P protein. Analysis of the total sample showed that each of the proteins was synthesized ( Fig. 2A) . Samples of HA FL L and FLAG Bam L expressed alone (Lanes 4 and 5) were mixed and all the samples were immunoprecipitated with a-HA antibody. There was no cross-reactivity of the HA antibody with the FLAG Bam L -P complex (Fig. 2B, Lane 3 ) and no L -L complex formation was observed when HA FL L and FLAG Bam L were synthesized separately and then mixed (Fig.  2B, Lane 4) . However, FLAG Bam L was coimmunoprecipitated with HA FL L by a-HA when the two proteins were translated together (Lane 5) as above. These data show that PIV3 L -L complex formation requires the coexpression of the L proteins.
Interaction of PIV3 and SV L with homologous and heterologous P proteins
The P binding site on L for formation of the polymerase complex has been studied for Sendai, SV5 and measles, but not for any other paramyxovirus (Chandrika et al., 1995; Holmes and Moyer, 2002; Horikami et al., 1994; Parks, 1994) . The PIV3 C-terminal L truncations were therefore tested for their ability to bind to PIV3 P utilizing a glutathione-S-transferase (gst) P fusion protein and pull down experiments with glutathione-Sepharose beads. PIV3 gstP was shown to be as active as wt P in a PIV3 CAT reporter minigenome replication assay (data not shown), and so was a valid reagent for these experiments. VVT7-infected cells were transfected with the gstP and full-length and Cterminal deletion FLAG L plasmids and labeled with Express-35 S. Gel analysis of the total samples showed that all the proteins were synthesized (Fig. 3A) . As controls, gstP alone bound to the beads, while the FL and truncated L proteins alone did not (Fig. 3B , Lanes 2, 5, 7 and 9). When coexpressed with gstP, FL L and both Bam L and Age L bound with gstP to the beads (Fig. 3B , Lanes 4, 6 and 8), showing complex formation. Sph L, however, was close to the size of gstP so that complex formation could not be assessed (Lane 10). As an alternative method, infected cells were transfected with the FLAG FL and truncated L plasmids and the P plasmid instead of gstP. IP with a-FLAG showed a small amount of background with P alone, but there was a significant increase of P coprecipitated with FL L, Bam L and Age L, but not with Sph L (Fig. 3C ). While the longer truncated L proteins bound P, truncation at aa 915 in Sph L abolished PIV3 P -L, but not L -L complex formation. Thus, the P binding site resides in the N-terminal 1305 aa of L.
There is considerable homology in the N-terminal half of the L proteins of PIV3 and Sendai (domains I-IV, Poch et al., 1990; Sidhu et al., 1993) . For the P proteins of the two viruses, there is little homology in the N-terminal half (23%), but 46% identity in the C-terminal 169 aa which contains the L binding site (Matsuoka et al., 1991) . We asked if heterologous P -L interactions occurred since under some conditions, PIV3, as well as PIV1, viruses, can replicate a Sendai template Pelet et al., 1996) . Infected cells were transfected with combinations of homologous and heterologous untagged L and gstP plasmids and complexes were selected with glutathione-Sepharose beads. Neither SV or PIV3 L bound in the absence of gstP, but as positive controls in the homologous samples, SV L was cobound with SV gstP to beads and PIV3 L and PIV3 gstP formed a complex (Fig. 3D , Lanes 2, 3, 6 and 7) as expected. When the heterologous interactions were tested, SV L did form a complex with PIV3 gstP at about 20% of the homologous interaction; however, in the reverse, there was no interaction of PIV3 L with SV gstP (Fig. 3D , Lanes 4 and 5), even in a longer exposure, although all the L proteins were equally expressed (not shown). The partial heterologous interaction in the one case suggests that some amino acids in common between the P proteins (and L proteins) of each virus are involved.
Heterologous L polymerase proteins do not function in RNA synthesis
To test the functional consequences of the heterologous L -L and P -L interactions that did occur (Figs. 1 and 3), various combinations of P and L were tested for transcription on homologous and heterologous templates (Fig.  4) . Previous experiments had shown that the homologous N protein is required for the Sendai and PIV3 poly- merases to transcribe a heterologous template and that P of one virus does not bind the heterologous nucleocapsid (Pelet et al., 1996) . However, it had not been tested if heterologous L proteins could be utilized with the homologous P, which was addressed here. VVT7-infected cells were transfected with no plasmids (Mock) or on the left with SV P and the indicated untagged SV or PIV3 L plasmids or on the right with PIV3 P and the indicated untagged PIV3 or SV L plasmids. Cytoplasmic extracts were prepared, incubated with polymerase-free wt RNA-NP from SV on the left or RNA-N template from PIV3 on the right as indicated and assayed for transcription in vitro under conditions optimal for each virus as described under Materials and methods. The RNA transcripts were isolated and analyzed by agarose-urea gel electrophoresis. In the Mock-transfected samples, there was no RNA synthesis from either the PIV3 or SV template (Fig. 4 , Lanes 1 and 4) showing that no endogenous polymerase remained with the templates. There was, however, good transcription from each template with the homologous P and L proteins, but no RNA synthesis from the homologous P with the heterologous L protein (Fig. 4 , Lanes 2, 3, 5 and 6). Thus, even though the SV L protein could form some complex with the PIV3 P protein, this complex was not active in transcription of the PIV3 template. Virtually no complex occurred between PIV3 L and SV P consistent with the lack of activity on the SV template. 
Interaction of PIV3 L with homologous and heterologous C proteins
In Sendai virus, the C protein binds the L polymerase protein to inhibit viral RNA synthesis (Cadd et al., 1996; Curran et al., 1992; Grogan and Moyer, 2001; Horikami et al., 1997) . To determine if these properties are the same for PIV3, the PIV3 C-terminal L truncations were also tested for their ability to bind to PIV3 gstC protein utilizing pull down experiments as above. VVT7-infected cells were transfected with the gstC and FL and C-terminal deletion FLAG L plasmids alone or together and pulse labeled with Express-35 S. Gel analysis of the total samples showed that all the proteins were synthesized (Fig. 5A) . As controls for C binding, gstC alone, but neither FL L nor the truncations alone, bound to the beads (Fig. 5B, Lanes 2, 3 , 5, 7 and 9). The PIV3 gstC protein appears as two bands, so the protein seems to undergo either early termination or proteolysis in cells, although not during in vitro transcription and translation in a rabbit reticulocyte lysate (data not shown). When coexpressed with gstC, FL L and each L deletion cobound to the beads (Lanes 4, 6, 8 and 10) , showing that PIV3 C does bind L and the C binding site resides in the N-terminal half of the L protein. While the largest C-terminal deletion, Sph L to 915 aa, inhibited L -P complex formation, the overall structure of the protein was not disrupted, because both C and L binding were retained with Sph L.
There is considerable homology throughout the C proteins of PIV3 and SV with an overall identity of 41% and 58% in the C-terminal 94 aa of the protein (Luk et al., 1986 ), so we asked if heterologous C -L interactions occurred. Infected cells were transfected with homologous and heterologous untagged FL L and gstC plasmids and complexes selected with glutathione-Sepharose beads. Neither SV or PIV3 L bound in the absence of any gstC; however, SV L was cobound with SV gstCV to beads and similarly PIV3 L and PIV3 gstC formed a complex (Fig. 5C , Lanes 2, 3, 6 and 7). When the heterologous interactions were tested, both SV L and PIV3 L did form a complex with the heterologous gstC protein at about 30 -50% of the homologous interaction (Fig. 5C, Lanes 4 and 5) . Thus, amino acids in common between the C proteins (and L proteins) of the two viruses must be important for complex formation.
Heterologous C proteins inhibit viral RNA synthesis with PIV3 and SV templates
To test the functional consequences of the observed heterologous C -L interactions, the different C proteins were tested for inhibition of overall RNA synthesis in a PIV3 reporter minigenome assay and for in vitro transcription on homologous and heterologous templates (Fig. 6 ). In the CAT reporter minigenome assay, T7 RNA polymerase transcribes a minus sense CAT RNA containing the termini of PIV3 genomic RNA from a plasmid. Encapsidation by the N protein creates a template that can be replicated and transcribed by the viral P -L polymerase complex (Durbin et al., 1997) . VVT7-infected cells were transfected with plasmids encoding the PIV3 P, N and L proteins, along with the pCAT minigenome plasmid and increasing amounts of the PIV3 gstC or SV gstCVplasmids. CAT enzyme activity in extracts of the cells was assayed as described under Materials and methods as a measure of polymerase activity. The PIV3 L, P and N proteins in the absence of gstC gave good levels of minigenome transcription and replication (Fig. 6A, top) . The addition of increasing amounts of the homologous PIV3 gstC plasmid completely inhibited minigenome transcription and replication. Gst itself gave no inhibition (data not shown), showing that the inhibitory effect is due to the C portion of the fusion protein. Similar amounts of the heterologous SV gstCValso inhibited PIV3 RNA synthesis, but to only 47% of the control. Immunoblot analysis of the samples with a-gst antibody showed that SV gstCV was actually expressed at higher levels than PIV3 gstC (Fig. 6A, bottom) .
To measure just transcription from purified viral templates, VVT7-infected cells were transfected with no plasmids (Mock) or with PIV3 P and L and the indicated PIV3 gstC or SV gstCVplasmids (Fig. 6B ) or with SV P and L and the indicated SV or PIV3 gstC plasmids (Fig. 6C) . Cytoplasmic extracts were prepared, incubated with polymerasefree wt RNA-N template from PIV3 (B) or RNA-NP from SV (C) and assayed for transcription in vitro. In the Mocktransfected samples, there was no RNA synthesis from either template; however, there was good transcription from each template with the homologous P and L proteins ( Fig.  6B and C, Lanes 1 and 2). Increasing amounts of PIV3 gstC in the PIV3 reactions showed a dose dependent inhibition of transcription, while SV gstCV gave 67% inhibition at the highest concentration of protein (Fig. 6B) . A similar result was obtained in the converse heterologous experiment. With the SV template, homologous SV gstCV gave nearly complete inhibition, but PIV3 gstC inhibited SV transcription by only 50% (Fig. 6C) . Thus, the interaction of PIV3 and SV C proteins with the heterologous L proteins leads to significant, but not complete inhibition of viral transcription, suggesting contributions of virus-specific regions of C protein to activity.
Discussion
We recently demonstrated that the L protein of Sendai virus is an oligomer within the P-L complex (C ßevik et al., 2003; Smallwood et al., 2002a Smallwood et al., ,2002b and wanted to test if other members of the paramyxovirus family shared a similar organization of the polymerase. We chose human parainfluenza virus 3 because it belongs to the same respirovirus genus as Sendai virus, the P protein is an oligomer De et al., 2000) and has similar mechanisms of transcription and replication, yet it is not as closely related to Sendai virus as is human parainfluenza virus 1. Coimmunoprecipitation of differentially epitope tagged full-length and truncated PIV3 L proteins with antibodies specific for the tag showed that an L -L complex does form (Fig. 1) , which does not depend on the P protein within the P -L complex. Complex formation does require the coexpression of the tagged L proteins (Fig. 2) The availability of tagged C-terminal truncations of PIV3 L protein allowed the determination of the binding sites of the viral P and C proteins which are expected to form complexes with L protein. PIV3 P protein bound C-terminal truncations of L to 1721 and 1305 aa but was abolished by deletion to aa 915 (Fig. 3) . Similar binding of the P proteins of SV5 and Sendai requiring the N-terminal half of their respective L proteins to form the polymerase complex was previously reported (Chandrika et al., 1995; Parks, 1994) , but for measles virus, just the N-terminal 408 aa of L still bound measles P (Horikami et al., 1994) . Confirmation of the importance of the very N terminus of L was shown by site-directed mutants in both Sendai and PIV3 L which abolished P binding (Holmes and Moyer, 2002; Malur et al., 2002) .
The function of the PIV3 C protein had not been analyzed directly, so we used the PIV3 L truncations to test C binding to L and tested for its biological activity. The PIV3 C protein bound to the full-length L and all the L truncations so a C -L complex formed and the binding site mapped to the Nterminal half of L, overlapping the L (Fig. 1) and P (Fig. 5 ) binding sites. This is similar to the data for Sendai where the C proteins bind to the N-terminal 895 aa of the Sendai L polymerase subunit, overlapping but different than the P binding site (C ßevik et al., 2003; Holmes and Moyer, 2002; Horikami et al., 1997) . The C protein of rinderpest virus was also shown to bind its L protein and infection with virus lacking C in cell culture gave lower growth and was deficient in mRNA synthesis (Baron and Barrett, 2000; Sweetman et al., 2001) . Like the inhibition of viral RNA synthesis by Sendai C proteins (Cadd et al., 1996) , analysis of PIV3 C function by a minigenome reporter assay and in vitro transcription showed that C inhibited PIV3 RNA synthesis in each case (Fig. 6 ). Previous analysis of mutations in the C protein of measles virus also showed that C inhibits measles RNA synthesis (Reutter et al., 2001) , presumably by also binding L protein, so the inhibitory function of C proteins in several different paramyxoviruses is similar.
To help in the identification of regions important for the L -L, L -P and L -C interactions, we tested for proteinprotein interactions between heterologous PIV3 and Sendai proteins and for biological function of these complexes in the transcription and replication of both viruses. Positive results would indicate that regions of like sequence between heterologous proteins are responsible for the binding sites. In fact the data showed that the L proteins of PIV3 and Sendai did form complexes with each other and that PIV3 gstP did bind Sendai L, although unexpectedly, Sendai gstP did not bind PIV3 L (Table 1) . It was previously reported that the PIV3 P -L complex did not function on the Sendai template, nor did Sendai P -L transcribe the PIV3 template, because the P protein of each polymerase was specific for homologous assembled N protein in the nucleocapsid template (Pelet et al., 1996) . The function of just heterologous L proteins in complex with the P protein specific for the template was not tested. We show here that heterologous P -L complexes are not active on either virus template (Fig.  4) , and we found that increasing amounts of the heterologous L protein to active transcription reactions of each virus did not act as dominant-negative proteins (S. Smallwood and S.A. Moyer, unpublished data) . Therefore, the heterologous Sendai and PIV3 P -L and L -L protein -protein interactions that do occur must be somehow incomplete or defective. Heterologous P and L interactions between Sendai and another serotype of PIV, PIV1, have been tested by Bousse et al. (2001) . Coimmunoprecipitation experiments showed complex formation between both SV P and PIV1 L as well as PIV1 P and SV L, whereas we observed a complex only with PIV3 P and SV L. Interestingly, the PIV1 P-SV L enzyme was active on a Sendai template (Bousse et al., 2001) , although here PIV3 P-SV L was not (Fig. 4) , so sequence differences between the P proteins of PIV3 and PIV1 must account for the loss of activity.
Analysis of heterologous C -L interactions showed that the C proteins of both Sendai and PIV3 did bind to the heterologous L proteins (Table 1) . In other studies, sitedirected mutations in the C-terminal half of Sendai C gave the loss of C binding to L and a loss of inhibitory activity (Grogan and Moyer, 2001) . Because these essential sites are identical between the Sendai and PIV3 C proteins, we predicted that the heterologous C protein would inhibit RNA synthesis of each virus. In fact this was the case (Table  1) , although inhibition was only to about 50% of the level of the homologous C protein, suggesting that amino acids of C specific for each virus, in addition to the identical sites in the C proteins, are important for the function of the protein. It is interesting that in a recent study, Kato et al. (2002) showed that PIV3 infection of a cell line constitutively expressing the smallest of the Sendai C proteins, Y2, had no effect on virus yield, even though the data presented here showed that Sendai C gave about a 50% inhibition of PIV3 RNA synthesis in vitro. Apparently, the reduction in RNA synthesis was not limiting in terms of virus production.
Materials and Methods
Cells, viruses and antibodies
A549 human lung carcinoma cells were used for all experiments. Sendai virus (Harris strain, SV) was propagated in embryonated chicken eggs and polymerase-free nucleocapsid template (RNA-NP) was purified as described previously (Carlsen et al., 1985 , Horikami et al., 1992 . Wild-type human PIV3 (JS) strain was grown in LLC-MK2 cells, purified and polymerase-free nucleocapsid template purified as described previously (Feller et al., 2000a,b) . A vaccinia virus recombinant which expresses the bacteriophage T7 Table 1 Homologous and heterologous interactions between Sendai (SV) and PIV 3 L, P and C proteins RNA polymerase (VVT7) (Fuerst et al., 1986) was grown in A549 cells. Antibodies included: rabbit anti-gst antibody (Chandrika et al., 1995) ; anti-FLAG M-2 monoclonal antibody (a-FLAG, Sigma); and anti-HA probe F-7 monoclonal antibody (a-HA, Santa Cruz Biotechnology, Inc.).
Plasmids
The pGem plasmids containing the Sendai virus L, NP and Pstop (designated P, expressing only P due to a stop codon in the C open reading frames) genes under the control of the T7 promoter were described previously . The Sendai pTM1gstP and pTM1gstCVplasmids were described previously (Chandrika et al., 1995; Horikami et al., 1997) . The Sendai HA and FLAG tagged full-length and truncated L plasmids were described in Smallwood et al. (2002a,b) . The pTMI plasmids for the PIV3 N, P (which does not express C protein) and L genes and the minigenome HPIV3-CAT +2 plasmid were described by Durbin et al. (1997) . The PIV3 pTM1-gstC plasmid was constructed by PCR amplification of the C open reading frame from the PIV3 P plasmid with primers containing BamHI and XhoI restriction sites and cloned into pTM1-gst at those sites so the gene was fused in frame at the C terminus of gst. The correct gene was confirmed by sequencing. PIV3 pTM1-gstP was constructed by subcloning P from pTM1-P into pTM1-gst at the BamHI and SalI restriction sites so the gene was fused in frame at the C terminus of gst.
To construct PIV3 L with HA or FLAG epitopes, the 5V end of the L gene was first amplified by PCR with Vent polymerase using an upstream primer with an AflII site before the start of the L coding start site and a primer downstream of the TthlllI site in L. The product was digested with Tth111I and blunted with T4 DNA polymerase, followed by digestion with AflII. This PIV3 L PCR fragment was then cloned into the AflII and SmaI sites in pTM1 vectors which contained either a FLAG or HA epitope tag with an in frame AflII site at the 3V end (E. Vrotsos and S. Moyer, unpublished data) to create intermediate vectors containing the 5Vend of PIV3 L fused to the 3V terminus of each epitope tag. Transformants were screened by PCR and positive clones confirmed by sequencing. To construct HA and FLAG tagged full-length PIV3 L, PIV3 pTM1-L was digested with SalI and XcmI and cloned into the epitope tagged intermediates at the SalI and XcmI sites. The resulting clones were designated PIV3 FLAG L and PIV3 HA L. To construct C-terminal truncations, PIV3 fulllength FLAG L was digested with BamHI and SalI, AgeI and SalI, or SphI and SalI, blunted with T4 DNA polymerase and ligated with T4 DNA ligase to yield: FLAG Bam L; FLAG Age L; and FLAG Sph L, respectively.
Protein synthesis and analysis
A549 cells in 60-mm dishes were infected with VVT7 at a multiplicity of infection (moi) of 2.5 pfu/cell for 1 h at 37jC. In different experiments, the cells were then transfected with the indicated combinations of plasmids PIV3 pTM1-P (0.6 Ag) or pTM1-gstP (0.6 Ag), the PIV3 tagged full-length (0.9 Ag) or truncated pTM1-L (0.45 Ag), SV pTM1-gstP (0.2 Ag), SV pGEM-L (5 Ag), truncated SV BaK L (5 Ag) and PIV3 pTM1gstC (0.6 Ag) or SV pTM1-gstCV (0.2 Ag) using lipofectin (Invitrogen Life Technologies) according to the manufacturer's protocol in Opti-MEM (GIBCO). Eighteen hours posttransfection (p.t.), cells were labeled with Express-35 S (100 ACi/ml, Perkin-Elmer) for 1 h. Cytoplasmic extracts were prepared by scraping into 165 Al SV Salts (0.1 M HEPES [pH 8.5], 0.05 M NH 4 Cl, 7 mM KCl, and 4.5 mM MgOAc, and 1 Ag/ml aprotinin) with 0.25% Nonidet P-40 (NP-40). The cell lysate was clarified by pelleting for 30 min at 13,000 rpm and samples (70 Al) used for immunoprecipitation (IP) or bead-binding. For IP, the extracts were precleared with protein A beads (Sigma), incubated with the relevant antibody (a-FLAG or a-HA, see figure legends) according to the manufacturer's protocol for 1 h at 4 jC and protein A beads were then added. The immunocomplexes bound to the beads were pelleted, washed, and separated by 7.5% SDS-PAGE on a 20-cm gel. For gst bead-binding analysis, the samples were diluted in SV Salts + 0.25% NP-40 to a total volume of 450 Al. Blocked glutathione-Sepharose 4B beads (15 Al per sample, Pharmacia Biotech) were incubated with extracts for 15 min at 4 jC, pelleted and washed 3Â in 800 Al SV Salts + 0.25% NP-40. The proteins were separated by 7.5% SDS-PAGE on a 20-cm gel and visualized by autoradiography. For immunoblot analysis, cell extracts used for the CAT analysis were separated by 7.5% SDS-PAGE on a minigel and electroblotted onto nitrocellulose. The blot was probed with a-gst antibody to detect the gstC fusion protein and developed with conjugated goat anti-rabbit secondary antibody using the Enhanced Chemiluminescence (ECL) Protein Identification System (Amersham Life Science) according to the manufacturer's protocol.
PIV3 CAT minigenome assay and transcription in vitro
For the CAT assay, A549 cells (35-mm dishes) were infected withVVT7 at a moi of 10 PFU/cell and transfected with PIV3 pTM1-P (0.5 Ag), pTM1-N (0.5 Ag), pTM1-L (0.15 Ag) and the CAT minigenome plasmid (0.5 Ag) in lipofectin. The cells were incubated for 20 h, scraped and pelleted, washed with 1 ml of 40 mM Tris, pH 7.5, 1 mM EDTA, 150 mM NaCl and resuspended in 50 Al 0.25 M Tris, pH 7.5. The lysate was prepared by three cycles of freezethaw and clarified by centrifugation. For the CAT assay (Sleigh, 1986) , 40 Al of the supernatant was added to 60 Al of reaction mix containing: 20 Al 8 mM chloramphenicol, 20 Al 14 C-acetyl coenzyme A (5 ACi/ml) in 0.25 mM Tris -HCl, pH 7.8 and 20 Al 0.25 M Tris -HCl, pH 7.8 and the samples incubated at 37 jC for 2.5 h. The radiolabeled 14 C-chloramphenicol product was extracted with cold ethyl acetate (100 Al) and quantitated in the scintillation counter.
For mRNA synthesis, A549 cells in 60-mm dishes were infected with VVT7 at an moi of 2.5 PFU/cell for 1 h at 37 jC and transfected with PIV3 pTM1-P (0.45 Ag) and pTM1-L (0.15 Ag) in the absence or presence of the indicated amounts of PIV3 pTM1-gstC or SV pTM1-gstCV in lipofectin in Opti-MEM (Life Technologies) and incubated at 37 jC for 18 h p.t. Cytoplasmic extracts (100 Al) were prepared using the lysolecithin procedure as described by De et al. (1990) except NH 4 Cl was at 150 mM instead of 50 mM. The extracts were treated with micrococcal nuclease (12 Ag/ml) in 1 mM CaCl 2 for 30 min at 30 jC, EGTA (2.2 mM) added and then incubated with polymerase-free PIV3 RNA-N template (2 Ag) and [a 32 P]-CTP (40 ACi) for 2 h at 30 jC. The total labeled transcription products were purified over RNeasy columns (Qiagen) and analyzed by electrophoresis on 1.5% agarose-acid-urea gels. The products were visualized by autoradiography and quantitated using a PhosphorImager (Molecular Dynamics).
Sendai virus transcription
A549 cells in 60-mm dishes were infected with VVT7 at an moi of 2.5 PFU/cell for 1 h at 37 jC. The infected cells were washed with Opti-MEM and transfected with SV L (0.5 Ag) and SV P (1.5 Ag) plasmids in lipofectin in the absence or presence of the indicated amounts of PIV3 gstC or SV gstCV plasmids and incubated at 37 jC in Opti-MEM (Life Technologies). At 18 h p.t., cytoplasmic extracts (100 Al) were prepared using a modification of the lysolecithin procedure (Horikami et al., 1992) where the cells are scraped into incomplete reaction mix, micrococcal nuclease digested and then supplemented with magnesium acetate, RNasin, actinomycin D, creatine phosphate and creatine phosphokinase (Chandrika et al., 1995) . To assay for mRNA synthesis, wt Sendai RNA-NP template (1 Ag) and [a 32 P]-CTP (20 ACi) were added to each extract. After incubation for 2 h at 30 jC, the total labeled products were purified over RNeasy columns (Qiagen) and analyzed by electrophoresis on 1.5% agarose-acid-urea gels. The products were visualized by autoradiography and quantitated using a PhosphorImager.
